A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021

References

• Puustinen L, Barner-Rasmussen N, Pukkala E, et al. Incidence, prevalence, and causes of death of patients with autoimmune hepatitis: a nationwide register-based cohort study in Finland. Digestive Liver Dis. 2019;51(9):1294–6.
   Web of Science ®Google Scholar
• Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012;56(5):1181–1188.
   PubMed Web of Science ®Google Scholar
• Grønbæk L, Vilstrup H, Jepsen P. Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study. J Hepatol. 2014;60(3):612–617.
   PubMed Web of Science ®Google Scholar
• Grønbæk L, Otete H, Ban L, et al. Incidence, prevalence and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study. Liver Int. 2020;40(7):1634–1644.
   PubMed Web of Science ®Google Scholar
• Boberg KM, Aadland E, Jahnsen J, et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33(1):99–103.
   PubMed Web of Science ®Google Scholar
• Jepsen P, Grønbæk L, Vilstrup H. Worldwide incidence of autoimmune liver disease. Dig Dis. 2015;33(Suppl 2):2–12.
   PubMedGoogle Scholar
• Tanaka A. Autoimmune Hepatitis: 2019 Update. Gut Liver. 2020;14(4):430–438.
   PubMed Web of Science ®Google Scholar
• Sharma R, Verna EC, Söderling J, et al. Increased mortality risk in autoimmune hepatitis: a nationwide population-based cohort study with histopathology. Clin Gastroenterol Hepatol. 2021;19(12):2636–2647.e13.
   PubMed Web of Science ®Google Scholar
• Marschall HU, Henriksson I, Lindberg S, et al. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Sci Rep. 2019;9(1). doi:10.1038/S41598-019-47890-2
   Google Scholar
• Chazouillères O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28(2):296–301.
   PubMed Web of Science ®Google Scholar
• Rust C, Beuers U, Of Gastroenterology P. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008;14(21):3368. doi: 10.3748/wjg.14.3368. Published online 2008.
   PubMed Web of Science ®Google Scholar
• Loftus EV, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54(1):91–96. doi: 10.1136/gut.2004.046615
   PubMed Web of Science ®Google Scholar
• Mehta TI, Weissman S, Fung BM, et al. Global incidence, prevalence and features of primary sclerosing cholangitis: a systematic review and meta-analysis. Liver Int. 2021;41(10):2418–2426.
   PubMed Web of Science ®Google Scholar
• Carbone M, Kodra Y, Rocchetti A, et al. Primary sclerosing cholangitis: burden of disease and mortality using data from the national rare diseases registry in Italy. doi:10.3390/ijerph17093095
   Google Scholar
• Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology. 2013;58(6):2045–2055.
   PubMed Web of Science ®Google Scholar
• Hammer T, Nielsen KR, Munkholm P, et al. The Faroese IBD study: incidence of inflammatory bowel diseases across 54 years of population-based data. J Crohns Colitis. 2016;10(8):934–942.
   PubMed Web of Science ®Google Scholar
• Tygstrup N, Steig B, Juijn JA, et al. Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity. Hepatology. 1999;29(2):506–508.
   PubMed Web of Science ®Google Scholar
• Holm E, Holm M, Vilhelmsen K, et al. Prevalence of open-angle glaucoma in the Faroese population. J Glaucoma. 2022;31(2):72–78.
   PubMed Web of Science ®Google Scholar
• Rasmussen J, Nielsen OW, Janzen N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis. 2014;37(2):215–222.
   PubMed Web of Science ®Google Scholar
• Als TD, Jorgensen TH, Børglum AD, et al. Highly discrepant proportions of female and male Scandinavian and British Isles ancestry within the isolated population of the Faroe Islands. Eur J Hum Genet. 2006;14(4):497–504.
   PubMed Web of Science ®Google Scholar
• Jorgensen TH, Butteschön HN, Wang AG, et al. The origin of the isolated population of the Faroe Islands investigated using Y chromosomal markers. Hum Genet. 2004;115(1):19–28.
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Diagnosis and management of autoimmune hepatitis: current status and future directions. Gut Liver. 2016;10(2):177–203.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237–267. doi:10.1016/J.JHEP.2009.04.009
   PubMed Web of Science ®Google Scholar
• Björnsson ES, Kalaitzakis E. Recent advances in the treatment of primary sclerosing cholangitis. Expert Rev Gastroenterol Hepatol. 2021;15(4):413–425.
   PubMed Web of Science ®Google Scholar
• Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases. Hepatology. 2020;72(2):671–722.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. www.R-project.org.
   Google Scholar
• Kuiper EMM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8(6):530–534.
   PubMed Web of Science ®Google Scholar
• Zhang W, De D, Mohammed KA, et al. New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome. Hepatol Commun. 2018;2(3):245–253. doi:10.1002/HEP4.1148
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Chazouillères O, Cortez-Pinto H, et al. A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients. Expert Rev Gastroenterol Hepatol. 2021;15(8):929–939. doi:10.1080/17474124.2021.1945919
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Beuers U, Corpechot C, et al. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145–172. doi:10.1016/J.JHEP.2017.03.022
   PubMed Web of Science ®Google Scholar
• Valgeirsson KB, Hreinsson JP, Björnsson ES. Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver Int. 2019;39(12):2341–2349.
   PubMed Web of Science ®Google Scholar
• Werner M, Prytz H, Ohlsson B, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2009;43(10):1232–1240. doi: 10.1080/00365520802130183
   Web of Science ®Google Scholar
• Jacobsen EW, Pedersen OB, Andorsdóttir G, et al. Family recurrence risk of alopecia areata in the Faroe Islands. Clin Exp Dermatol. 2019;44(7):e224–e229.
   PubMed Web of Science ®Google Scholar
• Hammer T, Lophaven SN, Nielsen KR, et al. Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development. Aliment Pharmacol Ther. 2017;45(8):1107–1114.
   PubMed Web of Science ®Google Scholar
• Burisch J, Pedersen N, Čuković-Čavka S, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2014;63(4):588–597. doi:10.1136/gutjnl-2013-304636
   PubMed Web of Science ®Google Scholar
• Machado M, del Pilar Fortes M, Gil G, et al. Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela. Liver Int. 2007;27(10):1409–1416.
   PubMed Web of Science ®Google Scholar
• Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386(10003):1565–1575.
   PubMed Web of Science ®Google Scholar
• Gazda J, Drazilova S, Janicko M, et al. The epidemiology of primary biliary cholangitis in European countries: a systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2021;2021:1–11.
   Web of Science ®Google Scholar
• Lucey MR, Neuberger JM, Williams R. Primary biliary cirrhosis in men. Gut. 1986;27(11):1373–1376.
   PubMed Web of Science ®Google Scholar
• Neuberger J, Lombard M, Galbraith R. Primary biliary cirrhosis. Gut. 1991;Suppl(Suppl):S73–S78.
   PubMedGoogle Scholar
• Apol KD, Lydersen LN, Mortensen Ó, et al. FarGen – participants in the genetic research infrastructure of the Faroe Islands. Scand J Public Health. 2022;50(7):980–987. Published online 2021. doi:10.1177/14034948211046817
   PubMed Web of Science ®Google Scholar
• Czaja AJ. Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci. 2013;58(6):1459–1476.
   PubMed Web of Science ®Google Scholar
• Bosch DE, Zen Y, Boukhar SA, et al. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Virchows Arch. 2021;479(6):1131–1143.
   PubMed Web of Science ®Google Scholar
• Trivedi PJ, Lammers WJ, Van Buuren HR, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut. 2016;65(2):321–329.
   PubMed Web of Science ®Google Scholar